NEW YORK (GenomeWeb) – Researchers from University College London reported in Genome Medicine this week that a DNA methylation signature they've uncovered could predict the risk of a woman developing breast cancer.

Although they developed the signature by examining the blood of women who are BRCA1 carriers, it appeared to also be able to predict risk of non-hereditary breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.